False
September 28, 2026
2 min read
Renee Aguiar-Lucander argues that faster clinical trials and more pragmatic regulation are essential to bringing medicines to patients sooner
September 28, 2026
3 min read
Phase I study will test whether a targeted lentiviral vector can generate BCMA-directed CAR T cells inside patients with multiple myeloma
September 22, 2026
5 min read
CCRM CEO Michael May on quantum computing, commercialization, and the next era of cell therapy
September 21, 2026
2 min read
Four-year RESTORE results will shed new light on the durability of Nanoscope’s mutation-agnostic optogenetic therapy
False